Error loading player: No playable sources found
Coupling Mass Spectrometry (MS) with non-MS Assays for Automated Profiling of Antibody Impurities | Presented by Agilent Technologies
Date
January 30, 2025
This product is not available for individual purchase, but it is available as part of the following products:
Session Speaker:
Harsha Gunawardena, Johnson & Johnson Innovative Medicine
Speaker
General
Related Products
Parallel Session 6B: The Critical Need to Protect the Horseshoe Crab: Initiatives from Industry, Suppliers and Regulators to Replace the LAL Assay
The pharmaceutical industry is increasingly viewed as a key sector systemically important in reversing nature loss. One of the sector’s key dependencies is on the horseshoe crab , a species that is vital to marine ecosystems only located in a few locations globally…
Parallel Session 5A - Integrated Control Strategy for Combination Products
Drug-device combination products such as prefilled syringes, autoinjectors, etc. can play an important role to ensure patient convenience, compliance, and enhance therapeutic impact of the drug…
Parallel Session 2A - Science vs the Fear Factor: Alternative Potency Assays for Recombinant Biologics and Vaccines
Potency analytical control strategies are critical to support biopharmaceutical drug and vaccine development throughout the product lifecycle…
Parallel Session 2B- LER 2025: Strategies Today for Overcoming Low Endotoxin Recovery
Monitoring and control of endotoxin are critical aspects of an overall microbial control strategy necessary to ensure drug product quality and patient safety…
